CARBAMAZEPINE ER
Generic: CARBAMAZEPINE, CARBAMAZEPINE ER
Bostal LLCManufacturer
ORALRoute
CARBAMAZEPINEActive Substance
2022-03-31Original Approval
CARBAMAZEPINE ER is FDA application ANDA215591, sponsored by ZHEJIANG JIUZHOU. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
3,562 reports
2
DRUG INTERACTION
2,493 reports
3
TOXICITY TO VARIOUS AGENTS
2,360 reports
4
SEIZURE
2,013 reports
5
OFF LABEL USE
1,897 reports
6
FALL
1,864 reports
7
DIZZINESS
1,516 reports
8
PAIN
1,407 reports
9
FATIGUE
1,400 reports
10
PYREXIA
1,386 reports